Related Experiment Video
Updated: Sep 21, 2025

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
7.8K
Sleep clinic service model with closed-loop management for insomnia
Sugai Liang1, Andrew J Greenshaw2, Tao Li3
1Affiliated Mental Health Centre & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou 310013, Zhejiang, China.
Asian Journal of Psychiatry
|June 1, 2022
Summary
This study presents a new digital, patient-centered outpatient care model for insomnia. This collaborative approach aims to improve the efficiency and quality of insomnia treatment in clinical settings.
Area of Science:
- Sleep Medicine
- Digital Health
- Healthcare Management
Background:
- Insomnia is a prevalent condition often linked to other health issues, necessitating effective long-term outpatient management.
- Current clinical practices require optimized strategies for delivering consistent and high-quality insomnia care.
- The integration of digital health and collaborative care models is emerging as a key area for improving patient outcomes.
Purpose of the Study:
- To introduce and evaluate an innovative digital health-based, patient-centered, collaborative care model for outpatient insomnia management.
- To describe a closed-loop management system encompassing pre-diagnosis, diagnosis, treatment, and follow-up care for insomnia patients.
- To assess the potential of this model in balancing the efficiency and quality of outpatient medical services for insomnia.
Main Methods:
- Development of a digital health platform supporting patient-centered, collaborative care.
- Implementation of a closed-loop management system for insomnia patients within public hospital clinics.
- Integration of home-based treatment adherence monitoring and scheduled return visits for continuous care.
Main Results:
- The proposed model facilitates comprehensive medical care for insomnia patients throughout their treatment journey.
- It establishes a collaborative framework involving healthcare providers, patients, and digital tools.
- The model is designed to enhance the efficiency and quality of outpatient insomnia management.
Conclusions:
- The innovative outpatient service model offers a promising approach to managing insomnia.
- Digital health integration and collaborative care are key components for effective patient management.
- This patient-centered strategy has the potential to optimize the balance between efficiency and quality in insomnia care.
Related Concept Videos
Management of Insomnia
328
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
328
Insomnia
135
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
135
Sleep-Wake Cycles
1.7K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.7K
Narcolepsy
208
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
208
Sedatives and Hypnotics: Overview
714
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
714
Sedatives and Hypnotics Drugs: Miscellaneous Agents
250
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
250

